ArticleRadiology2019
Diffusion Tensor MRI to Distinguish Progressive Supranuclear Palsy from α-Synucleinopathies.
Abstract read
In one paragraph
Article in Radiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 28 citations in OpenAlex.
- Selective white matter tract vulnerability associated with tau burden in progressive supranuclear palsy and Alzheimer's disease.European journal of nuclear medicine and molecular imaging · 2026Article
- From clinical phenotypes to molecular precision: multimodal biomarkers for progressive supranuclear palsy.Frontiers in neuroscience · 2026Review
- Brainstem and cerebellar radiological findings in progressive supranuclear palsy.Brain communications · 2025Review
- Complemental Value of Microstructural and Macrostructural MRI in the Discrimination of Neurodegenerative Parkinson Syndromes.Clinical neuroradiology · 2024Article
- Differentiating between common PSP phenotypes using structural MRI: a machine learning study.Journal of neurology · 2023Article
- The use of neuroimaging techniques in the early and differential diagnosis of dementia.Molecular psychiatry · 2023Review
- Multimodality imaging of neurodegenerative disorders with a focus on multiparametric magnetic resonance and molecular imaging.Insights into imaging · 2023Review
- Magnetic resonance imaging modalities aid in the differential diagnosis of atypical parkinsonian syndromes.Frontiers in neurology · 2023Review
- Waiting impulsivity in progressive supranuclear palsy-Richardson's syndrome.Frontiers in neuroscience · 2023Article
- Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across Tauopathies.Journal of neuropathology and experimental neurology · 2022Article
- The tauopathies: Neuroimaging characteristics and emerging experimental therapies.Journal of neuroimaging : official journal of the American Society of Neuroimaging · 2022Review
- Multiparametric magnetic resonance imaging and positron emission tomography findings in neurodegenerative diseases: Current status and future directions.The neuroradiology journal · 2021Review
- Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology.Acta neuropathologica communications · 2021Article
- Preliminary Exploration of the Sequence of Nerve Fiber Bundles Involvement for Idiopathic Normal Pressure Hydrocephalus: A Correlation Analysis Using Diffusion Tensor Imaging.Frontiers in neuroscience · 2021Article
- Application of modern neuroimaging technology in the diagnosis and study of Alzheimer's disease.Neural regeneration research · 2021Article
- Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes.Frontiers in neurology · 2020Review
- Plasma neurofilament light protein correlates with diffusion tensor imaging metrics in frontotemporal dementia.PloS one · 2020Article
Corrections and comments
- Commented on by
Authors and funding
15 authors at 3 institutions in 4 countries.
Nicola SpotornoFrom the Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Sölvegatan 19, 22100 Lund, Sweden (N.S., S.H., D.v.W., O.H.); Penn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (N.S., D.J.I., M.G., C.T.M.); Memory Clinic, Skåne University Hospital, Malmö, Sweden (S.H., O.H.); Center for Neurodegenerative Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (D.J.I., E.B.L., J.Q.T.); Department of Diagnostic Radiology, Lund University, Lund, Sweden (T.R., D.v.W., M.N.); Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, University College London, London, England (J.A.C.); Parkinson's Disease and Movement Disorders Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (A.F.D., M.A.S.); Alzheimer's Disease Core Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (E.B.L., J.Q.T.); and Queensland Brain Institute, University of Queensland and Mater Misericordiae, Brisbane, Queensland, Australia (P.J.N.).ORCID 0000-0001-5404-8788
Sara HallFrom the Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Sölvegatan 19, 22100 Lund, Sweden (N.S., S.H., D.v.W., O.H.); Penn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (N.S., D.J.I., M.G., C.T.M.); Memory Clinic, Skåne University Hospital, Malmö, Sweden (S.H., O.H.); Center for Neurodegenerative Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (D.J.I., E.B.L., J.Q.T.); Department of Diagnostic Radiology, Lund University, Lund, Sweden (T.R., D.v.W., M.N.); Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, University College London, London, England (J.A.C.); Parkinson's Disease and Movement Disorders Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (A.F.D., M.A.S.); Alzheimer's Disease Core Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (E.B.L., J.Q.T.); and Queensland Brain Institute, University of Queensland and Mater Misericordiae, Brisbane, Queensland, Australia (P.J.N.).
David J IrwinFrom the Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Sölvegatan 19, 22100 Lund, Sweden (N.S., S.H., D.v.W., O.H.); Penn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (N.S., D.J.I., M.G., C.T.M.); Memory Clinic, Skåne University Hospital, Malmö, Sweden (S.H., O.H.); Center for Neurodegenerative Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (D.J.I., E.B.L., J.Q.T.); Department of Diagnostic Radiology, Lund University, Lund, Sweden (T.R., D.v.W., M.N.); Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, University College London, London, England (J.A.C.); Parkinson's Disease and Movement Disorders Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (A.F.D., M.A.S.); Alzheimer's Disease Core Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (E.B.L., J.Q.T.); and Queensland Brain Institute, University of Queensland and Mater Misericordiae, Brisbane, Queensland, Australia (P.J.N.).
Theodor RumetshoferFrom the Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Sölvegatan 19, 22100 Lund, Sweden (N.S., S.H., D.v.W., O.H.); Penn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (N.S., D.J.I., M.G., C.T.M.); Memory Clinic, Skåne University Hospital, Malmö, Sweden (S.H., O.H.); Center for Neurodegenerative Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (D.J.I., E.B.L., J.Q.T.); Department of Diagnostic Radiology, Lund University, Lund, Sweden (T.R., D.v.W., M.N.); Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, University College London, London, England (J.A.C.); Parkinson's Disease and Movement Disorders Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (A.F.D., M.A.S.); Alzheimer's Disease Core Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (E.B.L., J.Q.T.); and Queensland Brain Institute, University of Queensland and Mater Misericordiae, Brisbane, Queensland, Australia (P.J.N.).
Julio Acosta-CabroneroFrom the Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Sölvegatan 19, 22100 Lund, Sweden (N.S., S.H., D.v.W., O.H.); Penn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (N.S., D.J.I., M.G., C.T.M.); Memory Clinic, Skåne University Hospital, Malmö, Sweden (S.H., O.H.); Center for Neurodegenerative Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (D.J.I., E.B.L., J.Q.T.); Department of Diagnostic Radiology, Lund University, Lund, Sweden (T.R., D.v.W., M.N.); Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, University College London, London, England (J.A.C.); Parkinson's Disease and Movement Disorders Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (A.F.D., M.A.S.); Alzheimer's Disease Core Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (E.B.L., J.Q.T.); and Queensland Brain Institute, University of Queensland and Mater Misericordiae, Brisbane, Queensland, Australia (P.J.N.).ORCID 0000-0003-1174-5983
Andres F DeikFrom the Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Sölvegatan 19, 22100 Lund, Sweden (N.S., S.H., D.v.W., O.H.); Penn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (N.S., D.J.I., M.G., C.T.M.); Memory Clinic, Skåne University Hospital, Malmö, Sweden (S.H., O.H.); Center for Neurodegenerative Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (D.J.I., E.B.L., J.Q.T.); Department of Diagnostic Radiology, Lund University, Lund, Sweden (T.R., D.v.W., M.N.); Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, University College London, London, England (J.A.C.); Parkinson's Disease and Movement Disorders Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (A.F.D., M.A.S.); Alzheimer's Disease Core Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (E.B.L., J.Q.T.); and Queensland Brain Institute, University of Queensland and Mater Misericordiae, Brisbane, Queensland, Australia (P.J.N.).
Meredith A SpindlerFrom the Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Sölvegatan 19, 22100 Lund, Sweden (N.S., S.H., D.v.W., O.H.); Penn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (N.S., D.J.I., M.G., C.T.M.); Memory Clinic, Skåne University Hospital, Malmö, Sweden (S.H., O.H.); Center for Neurodegenerative Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (D.J.I., E.B.L., J.Q.T.); Department of Diagnostic Radiology, Lund University, Lund, Sweden (T.R., D.v.W., M.N.); Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, University College London, London, England (J.A.C.); Parkinson's Disease and Movement Disorders Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (A.F.D., M.A.S.); Alzheimer's Disease Core Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (E.B.L., J.Q.T.); and Queensland Brain Institute, University of Queensland and Mater Misericordiae, Brisbane, Queensland, Australia (P.J.N.).
Edward B LeeFrom the Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Sölvegatan 19, 22100 Lund, Sweden (N.S., S.H., D.v.W., O.H.); Penn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (N.S., D.J.I., M.G., C.T.M.); Memory Clinic, Skåne University Hospital, Malmö, Sweden (S.H., O.H.); Center for Neurodegenerative Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (D.J.I., E.B.L., J.Q.T.); Department of Diagnostic Radiology, Lund University, Lund, Sweden (T.R., D.v.W., M.N.); Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, University College London, London, England (J.A.C.); Parkinson's Disease and Movement Disorders Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (A.F.D., M.A.S.); Alzheimer's Disease Core Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (E.B.L., J.Q.T.); and Queensland Brain Institute, University of Queensland and Mater Misericordiae, Brisbane, Queensland, Australia (P.J.N.).
John Q TrojanowskiFrom the Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Sölvegatan 19, 22100 Lund, Sweden (N.S., S.H., D.v.W., O.H.); Penn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (N.S., D.J.I., M.G., C.T.M.); Memory Clinic, Skåne University Hospital, Malmö, Sweden (S.H., O.H.); Center for Neurodegenerative Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (D.J.I., E.B.L., J.Q.T.); Department of Diagnostic Radiology, Lund University, Lund, Sweden (T.R., D.v.W., M.N.); Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, University College London, London, England (J.A.C.); Parkinson's Disease and Movement Disorders Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (A.F.D., M.A.S.); Alzheimer's Disease Core Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (E.B.L., J.Q.T.); and Queensland Brain Institute, University of Queensland and Mater Misericordiae, Brisbane, Queensland, Australia (P.J.N.).ORCID 0000-0002-9239-8794
Danielle van WestenFrom the Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Sölvegatan 19, 22100 Lund, Sweden (N.S., S.H., D.v.W., O.H.); Penn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (N.S., D.J.I., M.G., C.T.M.); Memory Clinic, Skåne University Hospital, Malmö, Sweden (S.H., O.H.); Center for Neurodegenerative Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (D.J.I., E.B.L., J.Q.T.); Department of Diagnostic Radiology, Lund University, Lund, Sweden (T.R., D.v.W., M.N.); Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, University College London, London, England (J.A.C.); Parkinson's Disease and Movement Disorders Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (A.F.D., M.A.S.); Alzheimer's Disease Core Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (E.B.L., J.Q.T.); and Queensland Brain Institute, University of Queensland and Mater Misericordiae, Brisbane, Queensland, Australia (P.J.N.).ORCID 0000-0001-8649-9874
Markus NilssonFrom the Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Sölvegatan 19, 22100 Lund, Sweden (N.S., S.H., D.v.W., O.H.); Penn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (N.S., D.J.I., M.G., C.T.M.); Memory Clinic, Skåne University Hospital, Malmö, Sweden (S.H., O.H.); Center for Neurodegenerative Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (D.J.I., E.B.L., J.Q.T.); Department of Diagnostic Radiology, Lund University, Lund, Sweden (T.R., D.v.W., M.N.); Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, University College London, London, England (J.A.C.); Parkinson's Disease and Movement Disorders Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (A.F.D., M.A.S.); Alzheimer's Disease Core Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (E.B.L., J.Q.T.); and Queensland Brain Institute, University of Queensland and Mater Misericordiae, Brisbane, Queensland, Australia (P.J.N.).ORCID 0000-0002-3140-8223
Murray GrossmanFrom the Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Sölvegatan 19, 22100 Lund, Sweden (N.S., S.H., D.v.W., O.H.); Penn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (N.S., D.J.I., M.G., C.T.M.); Memory Clinic, Skåne University Hospital, Malmö, Sweden (S.H., O.H.); Center for Neurodegenerative Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (D.J.I., E.B.L., J.Q.T.); Department of Diagnostic Radiology, Lund University, Lund, Sweden (T.R., D.v.W., M.N.); Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, University College London, London, England (J.A.C.); Parkinson's Disease and Movement Disorders Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (A.F.D., M.A.S.); Alzheimer's Disease Core Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (E.B.L., J.Q.T.); and Queensland Brain Institute, University of Queensland and Mater Misericordiae, Brisbane, Queensland, Australia (P.J.N.).
Peter J NestorFrom the Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Sölvegatan 19, 22100 Lund, Sweden (N.S., S.H., D.v.W., O.H.); Penn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (N.S., D.J.I., M.G., C.T.M.); Memory Clinic, Skåne University Hospital, Malmö, Sweden (S.H., O.H.); Center for Neurodegenerative Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (D.J.I., E.B.L., J.Q.T.); Department of Diagnostic Radiology, Lund University, Lund, Sweden (T.R., D.v.W., M.N.); Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, University College London, London, England (J.A.C.); Parkinson's Disease and Movement Disorders Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (A.F.D., M.A.S.); Alzheimer's Disease Core Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (E.B.L., J.Q.T.); and Queensland Brain Institute, University of Queensland and Mater Misericordiae, Brisbane, Queensland, Australia (P.J.N.).ORCID 0000-0002-5860-5921
Corey T McMillanFrom the Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Sölvegatan 19, 22100 Lund, Sweden (N.S., S.H., D.v.W., O.H.); Penn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (N.S., D.J.I., M.G., C.T.M.); Memory Clinic, Skåne University Hospital, Malmö, Sweden (S.H., O.H.); Center for Neurodegenerative Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (D.J.I., E.B.L., J.Q.T.); Department of Diagnostic Radiology, Lund University, Lund, Sweden (T.R., D.v.W., M.N.); Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, University College London, London, England (J.A.C.); Parkinson's Disease and Movement Disorders Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (A.F.D., M.A.S.); Alzheimer's Disease Core Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (E.B.L., J.Q.T.); and Queensland Brain Institute, University of Queensland and Mater Misericordiae, Brisbane, Queensland, Australia (P.J.N.).
Oskar HanssonFrom the Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Sölvegatan 19, 22100 Lund, Sweden (N.S., S.H., D.v.W., O.H.); Penn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (N.S., D.J.I., M.G., C.T.M.); Memory Clinic, Skåne University Hospital, Malmö, Sweden (S.H., O.H.); Center for Neurodegenerative Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (D.J.I., E.B.L., J.Q.T.); Department of Diagnostic Radiology, Lund University, Lund, Sweden (T.R., D.v.W., M.N.); Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, University College London, London, England (J.A.C.); Parkinson's Disease and Movement Disorders Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (A.F.D., M.A.S.); Alzheimer's Disease Core Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (E.B.L., J.Q.T.); and Queensland Brain Institute, University of Queensland and Mater Misericordiae, Brisbane, Queensland, Australia (P.J.N.).
Lund University · SEThe University of Queensland · AUWellcome Centre for Human Neuroimaging · GB
Funding
Transgenic Mouse Models of Tau PathologiesP01AG017586 · NIA · UNIVERSITY OF PENNSYLVANIA · PI LEE, VIRGINIA M · 2000 to 2021
$37.3MProject IV "Tackling Heterogeneity of Cognitive Trajectory in LBD"U19AG062418 · NIA · UNIVERSITY OF PENNSYLVANIA · PI GROSSMAN, MURRAY · 2019 to 2023
$18.1MResistance and Vulnerability for Alzheimer's and Related PathologiesR56AG058732 · NIA · UNIVERSITY OF PENNSYLVANIA · PI MCMILLAN, COREY T · 2019 to 2019
$799kMultimodal Biomarkers in Frontotemporal Lobar DegenerationK01AG043503 · NIA · UNIVERSITY OF PENNSYLVANIA · PI MCMILLAN, COREY T · 2013 to 2017
$642kNIA NIH HHS K01 AG043503NIA NIH HHS P01 AG017586NIA NIH HHS R56 AG058732NIA NIH HHS U19 AG062418Wellcome Trust 203147/Z/16/Z
Abstract
Background The differential diagnosis of progressive supranuclear palsy (PSP) and Lewy body disorders, which include Parkinson disease and dementia with Lewy bodies, is often challenging due to the overlapping symptoms. Purpose To develop a diagnostic tool based on diffusion tensor imaging (DTI) to distinguish between PSP and Lewy body disorders at the individual-subject level. Materials and Methods In this retrospective study, skeletonized DTI metrics were extracted from two independent data sets: the discovery cohort from the Swedish BioFINDER study and the validation cohort from the Penn Frontotemporal Degeneration Center (data collected between 2010 and 2018). Based on previous neuroimaging studies and neuropathologic evidence, a combination of regions hypothesized to be sensitive to pathologic features of PSP were identified (ie, the superior cerebellar peduncle and frontal white matter) and fractional anisotropy (FA) was used to compute an FA score for each individual. Classification performances were assessed by using logistic regression and receiver operating characteristic analysis. Results In the discovery cohort, 16 patients with PSP (mean age ± standard deviation, 73 years ± 5; eight women, eight men), 34 patients with Lewy body disorders (mean age, 71 years ± 6; 14 women, 20 men), and 44 healthy control participants (mean age, 66 years ± 8; 26 women, 18 men) were evaluated. The FA score distinguished between clinical PSP and Lewy body disorders with an area under the curve of 0.97 ± 0.04, a specificity of 91% (31 of 34), and a sensitivity of 94% (15 of 16). In the validation cohort
Indexed as
AgedAnisotropyDiagnosis, DifferentialDiffusion Tensor ImagingFemaleHumansMaleRetrospective StudiesSensitivity and SpecificitySupranuclear Palsy, ProgressiveSwedenSynucleinopathies
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.